The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat.
Health Care Policies
Posted inCost of Care
Race to the Bottom: Boom Times
In this first part of our three-part series “Race to the Bottom,” we trace the origins of America’s generic drug industry — groundbreaking, bipartisan legislation signed by President Ronald Reagan that saved us trillions and also got us into trouble.
Posted inNews & Announcements
“Race to the Bottom”: A New Series from Tradeoffs on the Ailing Generic Drug Industry
Debuting Sept. 12, this three-part series examines the problems plaguing an industry that America now relies on to fill 9 out of every 10 prescriptions.
Posted inHealth Technology
Patients Push to Shape the Future of AI
One advocate’s vision for the crucial role patients must play in the growth of health care AI.
Posted inCost of Care
Sen. Bill Cassidy Wrestles with a $500 Billion Health Care Problem
Tradeoffs talks with Sen. Bill Cassidy about a new bipartisan effort to improve care for some of the country’s poorest, sickest patients.
Posted inCost of Care
Can Washington Make Medicare and Medicaid Work Better Together?
Poor, sick Americans are stuck in a Medicare-Medicaid maze. Is a fix in sight?
Posted inHealth Law
How Pushing Hospitals to Give Away More Free Care Could Backfire
Some lawmakers want nonprofit hospitals to give away more free care. But experts warn that could wind up being worse for patients.
Posted inHealth Law
5 Ways America’s Courts Could Change Health Care in 2024
Key court decisions in 2024 about prescription drug prices, abortion bans, gender-affirming care and the Affordable Care Act could change the way health care is delivered in America.
Posted inPublic Health
Experts Pick the Year’s Scariest Health Policy Studies
In a special Halloween edition of Research Corner, Tradeoffs Advisory Board members share some of the scariest health policy studies they’ve read this year.
Posted inPublic Health
A Quarter of Clinic Visits are No Longer with Doctors
A new study in The BMJ reveals that nurse practitioners and physician assistants now handle 25% of Medicare visits. The way those visits are billed makes it hard to know how that shift away from doctors is impacting care.